Make Medicines Affordable
  • Home
  • About
  • Where we work
  • News
  • Strategies
  • Resources
  • Resources
    • Best practices and models
    • Community publications
    • GSIPA2M 2018
    • Patents: the facts
    • Research
    • Resource
    • Roadmap
    • Trade agreements
    • TRIPS Agreement
    • Video

UN Secretary General’s High Level Panel on access to medicines report

Report: Promoting innovation and access to health technologies.

Resource

Download the 2016 final report.

Keep in Touch

Our email newsletter has latest news on developments and campaign actions

Twitter

  • RT @GlobalJusticeUK: "I joined this research trial out of solidarity and a belief in the common good. But I'm worried that this publicly-fu…

    5 days ago

Make Medicines Affordable Twitter

Facebook

Russian NGOs have opposed Gilead's patent on Truvada (TDF/FTC), recommended for HIV treatment, and as PrEP.
Russia pays around 40x more for Gilead's overpriced branded version: $200 per month, compared to $5 per month for quality-assured generic versions.
If the court revokes the patent it will save money and lives.
The next hearing is September 2020.
makemedicinesaffordable.org/russian-ngos-oppose-gileads-patent-for-hiv-drug-truvada/ ... See MoreSee Less

5 days ago  ·  

Photo

ITPC global Facebook
stage Created with Sketch.

© Copyright ITPC 2020 Cookies Contact us

Website by Maraid Design